This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
I am fearful that an erroneous impression will be gathered from the data presented in Dr. Budnick's article (A. M. A. Am. J. Dis. Child.90:286 [Sept.] 1955) and particularly from an excerpt of the paper that appeared in The Journal (160:209 [Jan. 21] 1956). Parenterally given reserpine used alone or in combination with other hypotensive agents has been, since 1953, and is the principal method of managing toxemia and hypertension in pregnant patients at the District of Columbia General Hospital. To date, over 2,400 patients have been treated. The nasal congestion that Dr. Budnick mentions certainly is present in a fair incidence of babies. Attention was called to this in a previous report from this hospital (Am. J. M. Sc.229:379 [April] 1955). In this regard, it would seem that serious complications might be avoided by not allowing the infants so affected to
Finnerty FA. RESERPINE AND THE NEWBORN INFANT. JAMA. 1956;160(11):997. doi:10.1001/jama.1956.02960460075020
Customize your JAMA Network experience by selecting one or more topics from the list below.